Dr. Yuelin He has dedicated more than 30 years to pediatric hematology and hematopoietic stem cell transplantation (HSCT), and is recognized as one of China’s leading experts in this field. She is the recipient of the Tenth "Soong Ching Ling Pediatric Award" and a key contributor to the “Clinical Study on Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Severe Mediterranean Anemia.”
Dr. He has independently or jointly completed over 1,200 HSCT procedures for children with severe thalassemia, various types of leukemia, lymphoma, aplastic anemia, congenital immunodeficiency disorders, autoimmune diseases, and other rare and complex hematologic conditions. She is particularly skilled in developing individualized transplantation strategies for high-risk, refractory, and relapsed cases, and excels in full-course management of critically ill pediatric patients.
She graduated from the First Military Medical University (now Southern Medical University), later trained at the Department of Pediatrics and Adolescent Medicine of Queen Mary Hospital, The University of Hong Kong, and has participated in collaborative HSCT research with leading centers in Italy and Japan. Dr. He has published more than 100 academic papers and has presented her work multiple times at major international meetings such as ASH and EHA, contributing significantly to the advancement and standardization of pediatric HSCT in China.
